Cycurion (NASDAQ:CYCU) versus Halma (OTCMKTS:HLMAF) Head-To-Head Comparison

Cycurion (NASDAQ:CYCU) and Halma (OTCMKTS:HLMAF) are both industrials companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk.

Analyst Ratings

This is a breakdown of current recommendations for Cycurion and Halma, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cycurion	1	1	1	0	2.00
Halma	0	2	4	1	2.86

Cycurion presently has a consensus price target of $7.00, suggesting a potential upside of 2,087.50%. Given Cycurion’s higher possible upside, research analysts plainly believe Cycurion is more favorable than Halma.

Valuation & Earnings

This table compares Cycurion and Halma”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cycurion	$15.13 million	0.24	-$23.67 million	($7.17)	-0.04
Halma	$3.46 billion	5.36	$498.99 million	N/A	N/A

Halma has higher revenue and earnings than Cycurion.

Institutional and Insider Ownership

6.6% of Cycurion shares are owned by institutional investors. 4.6% of Cycurion shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Cycurion and Halma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cycurion	-108.49%	-123.25%	-53.74%
Halma	N/A	N/A	N/A

Risk and Volatility

Cycurion has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500. Comparatively, Halma has a beta of 1.52, indicating that its stock price is 52% more volatile than the S&P 500.

Summary

Halma beats Cycurion on 10 of the 13 factors compared between the two stocks.

About Cycurion

Cycurion is a global leading provider of Network Communications and Information Technology Security Solutions. Our mission is to develop and deliver world-class, cutting-edge solutions for our clients, regardless of size or complication, expressly optimizing your IT environment to meet the business need and to keep projects on track and on budget.

About Halma

Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire safety, fire detection and fire suppression; safe movement in public, commercial, and industrial spaces; elevator safety; communications in emergencies; control of access in potentially hazardous industrial and commercial environments; electrical safety; and the safe management of pipelines and storage assets solutions. This segment serves shops and restaurants, healthcare facilities, and offices and stadiums; industrial and logistics assets; public spaces and critical infrastructure; and aerospace, and rail and automotive markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring, water and waste water analysis and treatment, gas analysis and detection, and optical analysis systems. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; components, devices and systems that provide information and analytics to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.